Practical Guidance: The Use of Social Media In Oncology Practice

被引:105
作者
Dizon, Don S.
Graham, David
Thompson, Michael A.
Johnson, Lisa J.
Johnston, Claire
Fisch, Michael J.
Miller, Robert
机构
[1] Brown Univ, Women & Infants Hosp, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Carle Physicians Grp, Urbana, IL USA
[3] ProHealth Care Reg Canc Ctr, Waukesha, WI USA
[4] Amer Soc Clin Oncol, Alexandria, VA USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
关键词
D O I
10.1200/JOP.2012.000610
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The penetration of social media into modern society has become a worldwide cultural phenomenon. Social media use widely accessible Web-based and mobile technologies to facilitate the creation and sharing of user-generated content in a collaborative and social manner. The uptake of social media in medicine provides new opportunities for health care professionals and institutions to interact with patients and other professionals. Oncologists may use social media as a platform for patient education and authoritative health messaging, for professional development and knowledge sharing, and for direct patient interaction, although this may be fraught with important legal and privacy concerns. In this article, a working group of the ASCO Integrated Media and Technology Committee explores how oncologists might responsibly use social media in their professional lives. Existing social media policies from hospitals, health systems, and pharmaceutical industries are examined to identify common concepts informing the development of future guidelines. Key principles identified include establishing institutional ownership of social media activities and safeguarding protected health information. Furthermore, oncologists must not confuse the roles of provider of information and provider of care, must understand regulations related to state licensure and medical records, and must recognize the importance of transparency and disclosure of potential conflicts of interest. social media may be particularly useful for raising the awareness of and recruitment to clinical trials, but compliance with federal and state regulations and areas under the purview of a local institutional review board must also be ensured. Examples of constructive use of social media in oncology with Facebook, Twitter, and YouTube are provided.
引用
收藏
页码:E114 / E124
页数:11
相关论文
共 11 条
[1]  
American Society of Clinical Oncology, ASCO GUID METH MAN E
[2]   The Patient-Doctor Relationship and Online Social Networks: Results of a National Survey [J].
Bosslet, Gabriel T. ;
Torke, Alexia M. ;
Hickman, Susan E. ;
Terry, Colin L. ;
Helft, Paul R. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (10) :1168-1174
[3]   Strategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review [J].
Caldwell, Patrina H. Y. ;
Hamilton, Sana ;
Tan, Alvin ;
Craig, Jonathan C. .
PLOS MEDICINE, 2010, 7 (11)
[4]   Trends in Twitter Use by Physicians at the American Society of Clinical Oncology Annual Meeting, 2010 and 2011 [J].
Chaudhry, Aafia ;
Glode, L. Michael ;
Gillman, Matt ;
Miller, Robert S. .
JOURNAL OF ONCOLOGY PRACTICE, 2012, 8 (03) :173-+
[5]   Physicians on Twitter [J].
Chretien, Katherine C. ;
Azar, Justin ;
Kind, Terry .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (06) :566-568
[6]  
Department of Health and Human Services, FED REG, V76
[7]  
Ferguson T., E PATIENTS THEY CAN
[8]  
Fox S., CANC 2 0 SUMMARY REC
[9]  
Madden M., PEW INTERNET AM LIFE
[10]  
McGowan B, 2011, MED 2 0 11 4 WORLD C